Equities

Key statistics

On Tuesday, Pfizer Inc (PFE:NYQ) closed at 36.20, -1.09% below its 52-week high of 36.60, set on Oct 12, 2017.
52-week range
Today
29.83Nov 03 201636.60Oct 12 2017
Markit short selling activity
Low
Med
High
Open35.93
High36.33
Low35.75
Bid36.20
Offer36.24
Previous close35.98
Average volume13.52m
Shares outstanding5.96bn
Free float5.92bn
P/E (TTM)26.21
Market cap214.27bn USD
EPS (TTM)1.37
USD
Annual div (ADY)1.28
USD
Annual div yield (ADY)3.56%
Div ex-dateAug 02 2017
Div pay-dateSep 01 2017
Next div ex-dateNov 09 2017
Next div pay-dateDec 01 2017
Data delayed at least 15 minutes, as of Oct 17 2017 21:00 BST.
More ▼

Investors Chronicle View

The last IC recommendation on Pfizer Inc shares was Hold at 4,299.00 on 02 Jun 2014Read the full article
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.